{
    "2018-12-03": [
        [
            {
                "time": "2018-12-03",
                "original_text": "上证50等指数样本股更新生效在即 9只券商股调出、医药股成赢家",
                "features": {
                    "keywords": [
                        "上证50",
                        "样本股",
                        "券商股",
                        "医药股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-03",
                "original_text": "药明康德H股12月3日起招股 发行区间设定64.1至71.5港元",
                "features": {
                    "keywords": [
                        "药明康德",
                        "H股",
                        "招股",
                        "发行区间"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-17",
                "original_text": "沪深300等指数17日起调整样本股",
                "features": {
                    "keywords": [
                        "沪深300",
                        "样本股",
                        "调整"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-12-03",
                "original_text": "药明康德H股询价区间确定：64-71港元 相对A股折价22%",
                "features": {
                    "keywords": [
                        "药明康德",
                        "H股",
                        "询价区间",
                        "折价"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-12-13",
                "original_text": "港股公告精选：药明康德发行1.16亿股H股，预期12月13日上市",
                "features": {
                    "keywords": [
                        "药明康德",
                        "H股",
                        "发行",
                        "上市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-03",
                "original_text": "早间公告：恩华药业未向任何国家出口芬太尼；药明康德将发行H股1.16亿股",
                "features": {
                    "keywords": [
                        "恩华药业",
                        "芬太尼",
                        "药明康德",
                        "H股",
                        "发行"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-02",
                "original_text": "【医药】江琦、赵磊：2018年12月月报：正本清源、结构升级，把握创新、升级的确定性方向-20181202",
                "features": {
                    "keywords": [
                        "医药",
                        "创新",
                        "升级",
                        "确定性方向"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}